Back to Search
LOWELL CHING, MD
MD
Cardiovascular Disease Physician
NPI: 1700953692IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
G45432(CA)
Education
UNIVERSITY OF HAWAII JOHN A. BURNS SCHOOL OF MEDICINE
Class of 1980
Research & Publications (20)
The first hypervariable region of the gp120 Env glycoprotein defines the neutralizing susceptibility of heterologous human immunodeficiency virus type 1 isolates to neutralizing antibodies elicited by the SF162gp140 immunogen.
PMID 18003732·J Virol·2008
8-other
Differential effects of neuromuscular blockers on twitches and tetani in the isolated rat muscle: a multiple comparison study using simultaneous confidence intervals.
PMID 18844723·Fundam Clin Pharmacol·2008
4-observational
Relationship between tumour endothelial cell apoptosis and tumour blood flow shutdown following treatment with the antivascular agent DMXAA in mice.
PMID 14970872·Br J Cancer·2004
7-preclinical
Induction of endothelial cell apoptosis by the antivascular agent 5,6-Dimethylxanthenone-4-acetic acid.
PMID 12085190·Br J Cancer·2002
3-trial
Evidence for Ca(2+) activation and inactivation sites on the luminal side of the cardiac ryanodine receptor complex.
PMID 10926870·Circ Res·2000
7-preclinical
Identification and characterization of the hypoxia-responsive element in human stanniocalcin-1 gene.
PMID 19628018·Mol Cell Endocrinol·2010
8-other
A role for interleukin-6 in spreading endothelial cell activation after phagocytosis of necrotic trophoblastic material: implications for the pathogenesis of pre-eclampsia.
PMID 18825657·J Pathol·2009
8-other
Enhancement of the action of the antivascular drug 5,6-dimethylxanthenone-4-acetic acid (DMXAA; ASA404) by non-steroidal anti-inflammatory drugs.
PMID 18696010·Invest New Drugs·2009
7-preclinical
Inducing gene expression of cardiac antioxidant enzymes by dietary phenolic acids in rats.
PMID 18547798·J Nutr Biochem·2009
7-preclinical
Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection.
PMID 18987148·J Virol·2009
8-other
Strength of commitment language in motivational interviewing and gambling outcomes.
PMID 19290696·Psychol Addict Behav·2009
8-other
Neutrophil influx and chemokine production during the early phases of the antitumor response to the vascular disrupting agent DMXAA (ASA404).
PMID 19649209·Neoplasia·2009
7-preclinical
Vitamin C enhances phagocytosis of necrotic trophoblasts by endothelial cells and protects the phagocytosing endothelial cells from activation.
PMID 19070894·Placenta·2009
8-other
IFN-beta-dependent inhibition of tumor growth by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
PMID 18338946·J Interferon Cytokine Res·2008
7-preclinical
Consequences of increased vascular permeability induced by treatment of mice with 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and thalidomide.
PMID 17473922·Cancer Chemother Pharmacol·2008
7-preclinical
Regio- and stereoselective biomimetic synthesis of oligostilbenoid dimers from resveratrol analogues: influence of the solvent, oxidant, and substitution.
PMID 19003831·Chemistry·2008
8-other
Antitumour action of 5,6-dimethylxanthenone-4-acetic acid in rats bearing chemically induced primary mammary tumours.
PMID 16944150·Cancer Chemother Pharmacol·2007
7-preclinical
The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis.
PMID 17562815·J Exp Med·2007
7-preclinical
Synthesis and biological activity of azido analogues of 5,6-dimethylxanthenone-4-acetic acid for use in photoaffinity labeling.
PMID 17616114·J Med Chem·2007
7-preclinical
The vascular disrupting agent, DMXAA, directly activates dendritic cells through a MyD88-independent mechanism and generates antitumor cytotoxic T lymphocytes.
PMID 17638914·Cancer Res·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6041 CADILLAC AVE
LOS ANGELES, CA 90034 - Phone
- (323) 857-2000
Quick Facts
- NPI
- 1700953692
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 46
- Publications
- 20
Are you this provider?
Claim Your Profile